Views & Analysis Designing digital solutions that drive adoption If any digital patient solution is to have an impact, adoption by its intended end users is critical.
News Akebia joins GSK in oral CKD anaemia market The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS
Digital Sponsored Innovation as Strategy: Enabling life sciences of the future Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.